The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Proton pump inhibitor use (PPI) in patients treated with immune checkpoint inhibitors (ICI) for advanced cancer: Survival and prior therapy.
 
Marium Husain
No Relationships to Disclose
 
Menglin Xu
No Relationships to Disclose
 
Sandipkumar Patel
No Relationships to Disclose
 
Andrew Johns
No Relationships to Disclose
 
Madison Grogan
No Relationships to Disclose
 
Mingjia Li
No Relationships to Disclose
 
Gabrielle Lopez
No Relationships to Disclose
 
Abdul Miah
No Relationships to Disclose
 
Rebecca Hoyd
No Relationships to Disclose
 
YunZhou Liu
No Relationships to Disclose
 
Mitchell Muniak
No Relationships to Disclose
 
Tyler Haddad
No Relationships to Disclose
 
Gabriel Tinoco
Consulting or Advisory Role - Deciphera; Intellisphere
 
Kari Lynn Kendra
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Novartis (Inst)
 
Gregory Alan Otterson
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Guardant Health; Novocure
Research Funding - Array BioPharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Revolution Medicines (Inst)
 
Carolyn J Presley
Consulting or Advisory Role - Onc Live; PotentiaMetrics
 
Daniel Spakowicz
No Relationships to Disclose
 
Dwight Hall Owen
Consulting or Advisory Role - theMednet
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst); Onc.AI (Inst); Palobiofarma (Inst)